- Home
- FERG vs BDX Comparison
FERG vs BDX Comparison
Compare FERG & BDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FERG | BDX |
|---|---|---|
| Founded | 1887 | 1897 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Miscellaneous | Medical/Dental Instruments |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 47.4B | 43.0B |
| IPO Year | 2024 | 1998 |
Fundamental Metrics
Financial Performance| Metric | FERG | BDX |
|---|---|---|
| Price | $237.05 | $191.00 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 13 |
| Target Price | ★ $268.54 | $186.00 |
| AVG Volume (30 Days) | ★ 3.7M | 1.9M |
| Earning Date | 06-02-2026 | 05-07-2026 |
| Dividend Yield | 1.39% | ★ 2.89% |
| EPS Growth | ★ 9.26 | N/A |
| EPS | ★ 5.56 | 1.59 |
| Revenue | ★ $30,762,000,000.00 | $21,840,000,000.00 |
| Revenue This Year | $7.98 | N/A |
| Revenue Next Year | $5.86 | $3.02 |
| P/E Ratio | ★ $43.57 | $120.75 |
| Revenue Growth | 3.80 | ★ 8.24 |
| 52 Week Low | $207.64 | $140.11 |
| 52 Week High | $271.64 | $213.08 |
Technical Indicators
Market Signals| Indicator | FERG | BDX |
|---|---|---|
| Relative Strength Index (RSI) | 45.25 | 74.67 |
| Support Level | $219.86 | $141.69 |
| Resistance Level | $268.63 | $196.05 |
| Average True Range (ATR) | 6.55 | 4.33 |
| MACD | -1.75 | 0.71 |
| Stochastic Oscillator | 2.87 | 90.46 |
Price Performance
Historical ComparisonAbout FERG Ferguson plc
Ferguson distributes plumbing and HVAC products to North American repair, maintenance, and improvement, new construction, and civil infrastructure markets. It serves over 1 million customers and sources products from 37,000 suppliers. Ferguson engages customers through approximately 1,700 North American branches, over the phone, online, and in residential showrooms. The firm sold its UK business in 2021 and is now solely focused on the North American market.
About BDX Becton Dickinson and Company
Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.